Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

634 results

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Summaries of opinion Remove Summaries of opinion filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Withdrawn applications Remove Withdrawn applications filter

Medicine type Conditional approval Remove Conditional approval filter Biosimilar Remove Biosimilar filter Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter

Sort by

List item

Human medicine European public assessment report (EPAR): Byfavo

remimazolam, Conscious Sedation
Date of authorisation: 26/03/2021, , Revision: 4, Authorised, Last updated: 16/02/2023
List item

Human medicine European public assessment report (EPAR): Bylvay

Odevixibat, Cholestasis, Intrahepatic
Date of authorisation: 16/07/2021, , , , Revision: 2, Authorised, Last updated: 05/10/2022
List item

Human medicine European public assessment report (EPAR): Byooviz

ranibizumab, Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Myopia, Degenerative
Date of authorisation: 18/08/2021, , , Revision: 5, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Cablivi (updated)

Caplacizumab, Purpura, Thrombotic Thrombocytopenic
Date of authorisation: 30/08/2018, , , Revision: 7, Authorised, Last updated: 14/03/2023
List item

Human medicine European public assessment report (EPAR): Calquence (updated)

Acalabrutinib, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 05/11/2020, , Revision: 4, Authorised, Last updated: 06/03/2023
List item

Human medicine European public assessment report (EPAR): Caprelsa (updated)

Vandetanib, Thyroid Neoplasms
Date of authorisation: 16/02/2012, , Revision: 24, Authorised, Last updated: 09/03/2023
List item

Human medicine European public assessment report (EPAR): Carvykti

ciltacabtagene autoleucel, Multiple Myeloma
Date of authorisation: 25/05/2022, , , , Revision: 1, Authorised, Last updated: 17/01/2023
List item

Human medicine European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma)

pegfilgrastim, Neutropenia
Date of authorisation: 19/12/2019, , , Revision: 7, Authorised, Last updated: 24/02/2023
List item

Human medicine European public assessment report (EPAR): Ceplene

Histamine dihydrochloride, Leukemia, Myeloid, Acute
Date of authorisation: 07/10/2008, , , Revision: 12, Authorised, Last updated: 30/01/2023
List item

Human medicine European public assessment report (EPAR): Cerdelga

eliglustat, Gaucher Disease
Date of authorisation: 19/01/2015, , , Revision: 13, Authorised, Last updated: 11/01/2022
List item

Human medicine European public assessment report (EPAR): Cevenfacta

Eptacog beta (activated), Hemophilia A; Hemophilia B
Date of authorisation: 15/07/2022, , Authorised, Last updated: 29/11/2022
List item

Human medicine European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau)

Chenodeoxycholic acid, Xanthomatosis, Cerebrotendinous; Metabolism, Inborn Errors
Date of authorisation: 10/04/2017, , , , Revision: 5, Authorised, Last updated: 15/12/2021
List item

Human medicine European public assessment report (EPAR): Cibinqo (updated)

Abrocitinib, Dermatitis, Atopic
Date of authorisation: 09/12/2021, , , Revision: 3, Authorised, Last updated: 30/03/2023
List item

Human medicine European public assessment report (EPAR): Cinryze

C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011, , Revision: 23, Authorised, Last updated: 10/10/2022
List item

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020, , , Revision: 41, Authorised, Last updated: 24/03/2023
List item

Human medicine European public assessment report (EPAR): Copiktra

duvelisib, Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Date of authorisation: 19/05/2021, , Revision: 2, Authorised, Last updated: 13/07/2022
List item

Human medicine European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva

SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020, COVID-19 virus infection
Date of authorisation: 24/06/2022, , Revision: 5, Authorised, Last updated: 17/02/2023
List item

Human medicine European public assessment report (EPAR): Crysvita

Burosumab, Hypophosphatemia, Familial; Hypophosphatemic Rickets, X-Linked Dominant; Osteomalacia
Date of authorisation: 19/02/2018, , , Revision: 10, Authorised, Last updated: 08/11/2022
List item

Human medicine European public assessment report (EPAR): Cyltezo

adalimumab, Hidradenitis Suppurativa; Arthritis, Psoriatic; Psoriasis; Crohn Disease; Arthritis, Juvenile Rheumatoid; Uveitis; Arthritis, Rheumatoid; Colitis, Ulcerative; Spondylitis, Ankylosing
Date of authorisation: 10/11/2017, , , Revision: 2, Withdrawn, Last updated: 06/03/2019
List item

Human medicine European public assessment report (EPAR): Daronrix

Whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs, Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 21/03/2007, , Withdrawn, Last updated: 02/07/2013
List item

Human medicine European public assessment report (EPAR): Daurismo

Glasdegib maleate, Leukemia, Myeloid, Acute
Date of authorisation: 26/06/2020, , , Revision: 4, Authorised, Last updated: 07/07/2021
List item

Human medicine European public assessment report (EPAR): Daxas

roflumilast, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 05/07/2010, , Revision: 19, Authorised, Last updated: 25/08/2022
List item

Human medicine European public assessment report (EPAR): Dectova

Zanamivir, Influenza, Human
Date of authorisation: 26/04/2019, , , Revision: 4, Authorised, Last updated: 08/10/2021
List item

Human medicine European public assessment report (EPAR): Defitelio

defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013, , , , Revision: 14, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Delstrigo

doravirine, lamivudine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 22/11/2018, , Revision: 10, Authorised, Last updated: 20/02/2023